Perspectives of nuclear diagnostic imaging in diabetic cardiomyopathy

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 3, 2010, Pages 208-216

  Sasso, F C ^a   Rambaldi, P F ^a   Carbonara, O ^a   Nasti, R ^a   Torella, M ^a   Rotondo, A ^a   Torella, R ^a   Mansi, L ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiomyopathy; Diabetes; Imaging

Indexed keywords

GLUCOSE;

AUTONOMIC NEUROPATHY; CARDIAC GATED IMAGING; CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; EXERCISE TEST; HEART; HEART MUSCLE; HUMAN; INNERVATION; INSULIN RESISTANCE; METABOLISM; OXIDATION REDUCTION REACTION; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; SCINTISCANNING;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOMYOPATHIES; CORONARY CIRCULATION; DIABETES COMPLICATIONS; EXERCISE TEST; GLUCOSE; HEART; HUMANS; INSULIN RESISTANCE; MYOCARDIUM; OXIDATION-REDUCTION; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE VENTRICULOGRAPHY;

EID: 77549086215     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.08.013     Document Type: Review

References (64)

1. Hamby R.I., Zoneraich S., and Sherman L. Diabetic cardiomyopathy. JAMA 229 (1974) 1749-1754
2. Joffe I.I., Travers K.E., Perreault-Micale C.L., Hampton T., Katz S.E., Morgan J.P., et al. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol 34 (1999) 2111-2119
3. Sohn D.W., Chai I.H., Lee D.J., Kim H.C., Kim H.S., Oh B.H., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30 (1997) 474-480
4. Rodrigues B., Cam M.C., and McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180 (1998) 53-57
5. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., et al. Myocardial cell death in human diabetes. Circ Res 87 (2000) 1123-1132
6. Kawaguchi M., Techigawara M., Ishihata T., Asakura T., Saito F., Maehara K., et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 12 (1997) 267-274
7. Brooks B.A., Franjic B., Ban C.R., Swaraj K., Yue D.K., Celermajer D.S., et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab 10 9 (2008 September) 739-746
8. Takahashi N., Nakagawa M., Saikawa T., Ooie T., Yufu K., Shigematsu S., et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 38 (2001) 232-237
9. Dutta K., Podolin D.A., Davidson M.B., and Davidoff A.J. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50 (2001) 1186-1192
10. Lopaschuk G.D., Collins-Nakai R.L., and Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res 26 (1992) 1172-1180
11. Ferrannini E., Santoro D., Bonadonna R., Natali A., Parodi O., and Camici P.G. Metabolic and hemodynamic effects of insulin on human hearts. Am J Phys 264 (1993) E308-E315
12. Camici P., Marraccini P., Marzilli M., Lorenzoni R., Buzzigoli G., Puntoni R., et al. Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. Am J Phys 257 (1989) E309-E317
13. Sasso F.C., Carbonara O., Cozzolino D., Rambaldi P., Mansi L., Torella D., et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients. J Am Coll Cardiol 36 (2000) 219-226
14. Sasso F.C., Carbonara O., Nasti R., Marfella R., Esposito K., Rambaldi P., et al. Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects. Eur Heart J 26 (2005) 1205-1212
15. Nuutila P., Knuuti J., Ruotsalainen U., Koivisto V.A., Eronen E., Teras M., et al. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Phys 264 (1993) E756-E762
16. Voipio-Pulkki L.M., Nuutila P., Knuuti M.J., Ruotsalainen U., Haaparanta M., Teras M., et al. Heart and skeletal muscle glucose disposal in type-2 diabetic patients as determined by positron emission tomography. J Nucl Med 34 (1993) 2064-2067
17. Young L.H., Zaret B.L., and Barrett E.J. Physiologic hyperinsulinemia stimulates lactate extraction by heart muscle in the conscious dog. Metab Clin Exp 38 (1989) 1115-1119
18. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48 8 (2006 October 17) 1548-1551
19. Pattoneri P., Sozzi F.B., Catellani E., Piazza A., Iotti R., Michelini M., et al. Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of myocardial performance index. Cardiovasc Ultrasound 6 (2008 June 5) 27
20. Iskander S., and Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32 (1998) 57-62
21. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
22. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Friedman J.D., and Shaw L.J. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 105 (2002) 823-829
23. Shaw L.J., Hachamovitch R., Berman D.S., Marwick T.H., Lauer M.S., Heller G.V., et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 33 (1999) 661-669
24. Brown K.A., Heller G.V., Landin R.S., Shaw L.J., Beller G.A., Pasquale M.J., et al. Early dipyridamole (99m) Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 100 (1999) 2060-2066
25. Wackers F.J., and Zaret B.L. Detection of myocardial ischemia in patients with diabetes mellitus. Circulation 105 (2002) 5-7
26. Ritchie J.L., Bateman T.M., Bonow R.O., Crawford M.H., Gibbons R.J., Hall R.J., et al. ACC/AHA Task Force report. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging): developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 25 (1995) 521-547
27. Kang X., Berman D.S., Lewin H., Miranda R., Erel J., Friedman J.D., et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 137 (1999) 949-957
28. Kang X., Berman D.S., Lewin H.C., Cohen I., Friedman J.D., Germano G., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138 (1999) 1025-1032
29. Sharir T., Germano G., Kavanagh P.B., Lai S., Cohen I., Lewin H.C., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single-photon emission computed tomography. Circulation 100 (1999) 1035-1042
30. Berman D.S., Hachamovitch R., Kiat H., Cohen I., Cabico J.A., Wang F.P., et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 26 (1995) 639-647
31. Germano G., Kiat H., Kavanagh P.B., Moriel M., Mazzanti M., Su H.T., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
32. Germano G., Erel J., Lewin H., Kavanagh P.B., and Berman D.S. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 30 (1997) 1360-1367
33. Akincioglu C., Berman D.S., Nishina H., Kavanagh P.B., Slomka P.J., Abidov A., et al. Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med 46 (2005) 1102-1108
34. Danias P.G., Papaioannou G.I., Ahlberg A.W., O'Sullivan D.M., Mann A., Boden W.E., et al. Usefulness of electrocardiographic-gated stress technetium-99-m sestamibi single photon emission computed tomography to differentiate ischemic from non ischemic cardiomyopathy. Am J Cardiol 94 (2004) 14-19
35. Spadafora M., Manganelli F., and Rosato G. Simultaneous quantitative assessment of myocardial perfusion and left ventricular function for detecting ischemic and nonischemic dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 31 Suppl. 2 (2004) 308
36. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
37. Gibson C.M., Cannon C.P., Murphy S.A., Marble S.J., Barron H.V., Braunwald E., and TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105 (2002) 1909-1913
38. Angeja B.G., Gunda M., Murphy S.A., Sobel B.E., Rundle A.C., Syed M., et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 105 (2002) 282-285
39. Di Carli M.F., and Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?. J Am Coll Cardiol 45 (2005) 50-53
40. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21 (1998) 1551-1559
41. Quiñones M.J., Hernandez-Pampaloni M., Schelbert H., Bulnes-Enriquez I., Jimenex X., Hernandez G., et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 140 9 (2004) 700-708
42. Prior J.O., Quiñones M.J., Hernandez-Pampaloni M., Facta A.D., Schindler T.H., Sayre J.W., et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111 18 (2005) 2291-2298
43. Sawada S., Hamoui O., Barclay J., Giger S., Fain R., Foltz J., et al. Usefulness of positron emission tomography in predicting long-term outcome in patients with diabetes mellitus and ischemic left ventricular dysfunction. Am J Cardiol 96 (2005) 2-8
44. Brown T.L., Merrill J., Volokh L., and Bengel F.M. Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated (82)rubidium myocardial perfusion PET. Eur J Nucl Med Mol Imaging 35 (2008) 336-342
45. Schinkel A.F., Poldermans D., Rizzello V., van Domburg R.T., Valmeka R., Elhendy A., et al. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction. J Nucl Med 47 1 (2006 January) 66-73
46. Schinkel A.F., Bax J.J., Valkema R., Elhendy A., van Domburg R.T., Vourvouri E.C., et al. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med 44 6 (2003 June) 877-883
47. Vitale G.D., deKemp R.A., Ruddy T.D., Williams K., and Beanlands R.S. Myocardial glucose utilization and optimization of 18F-FDG PET imaging in patients with non-insulin dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 42 (2001) 1730-1736
48. Herrero P., Peterson L.R., McGill J.B., Matthew S., Lesniak D., Dence C., et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 47 (2006) 598-604
49. O'Brien I.A., McFadden J.P., and Corrall R.J.M. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79 (1991) 495-502
50. Chen H.S., Hwu C.M., Kuo B.I., Chiang S.C., Kwok C.F., Lee S.H., et al. Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med 18 (2001) 268-273
51. Gerritsen J., Dekker J.M., TenVoorde B.J., Kostense P.J., Heine R.J., Bouter L.M., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24 (2001) 1793-1798
52. Scognamiglio R., Avogaro A., Casara D., Crepaldi C., Marin M., Palisi M., et al. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31 (1998) 404-412
53. Grassi G., and Esler M. How to assess sympathetic activity in humans. J Hypertens 17 (1999) 719-734
54. Stevens M.J., Dayanikli F., Raffel D.M., Allman K.C., Sandford T., Feldman E.L., et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 31 (1998) 1575-1584
55. Lange A., Freeman M.R., Josse R.G., and Armstrong P.W. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25 (1995) 610-618
56. Schnell O., Kirsch C.M., Stemplinger J., Haslbeck M., and Standl E. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38 (1995) 1345-1352
57. Patel A.D., and Iskandrian A.E. MIBG imaging. J Nucl Cardiol 9 (2002) 75-92
58. Diakakis G.F., Parthenakis F.I., Patrianakos A.P., Koukouraki S.I., Stathaki M.I., Karkavitsas N.S., et al. Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation. Cardiovasc Pathol 17 (2008) 172-177
59. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 (1999) 352-360
60. Arora R., Ferrick K.J., Nakata T., Kaplan R.C., Rozengarten M., Latif F., et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol 10 (2003) 121-131
61. ICRP Publication 80 Radiation dose to patients from radiopharmaceuticals. Ann ICRP 28 3 (1998) Pergamon Press, Oxford
62. Effects of ionizing radiation vol. 1-2 (2006), UN Scientific Committee on the Effect of Atomic Radiation. UNSCEAR Official Records of the UN General Assembly, 61 session, supplement n°46, 2008
63. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009. Appropriate use criteria for cardiac radionuclide imaging. J Am Coll Cardiol 53 23 (2009) 2201-2229
64. Young L.H., Wackers F.J.T., Chyun D.A., Davey J.A., Barrett E.J., Taillfer R., et al., for the DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA 301 15 (2009) 1547-1555